Micro Imaging Technology and Northern Michigan University to Investigate MIT 1000 Enhancement to Give More Rapid Pathogen Test Results
Marketwire - Tue Jul 29, 7:03AM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that it has funded the collaboration with Northern Michigan University (NMU) to investigate an alternative pathogen sample preparation method that could provide a specimen test turnaround time of 4 to 5 hours.
Micro Imaging Technology Adds Salmonella Choleraesuis to Its Catalog of Identifiers
Marketwire - Wed Jul 09, 7:02AM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that its MIT 1000 System can now identify Salmonella enterica serotype Choleraesuis. S. Choleraesuis is a non-typhoid strain that is a serious cause of foodborne infection. It also shows a higher predilection for causing bacteremia (bacteria in the blood) in humans by entering blood vessels through the stomach wall.
Micro Imaging Technology partners with Northern Michigan University for MIT 1000 System to identify pathogenic bacteria
M2 - Wed Mar 19, 8:38AM CDT
Pathogen testing company Micro Imaging Technology (OTCQB:MMTC) revealed on Tuesday the shipment of an MIT 1000 System to identify and differentiate Staphylococcus aureus (S. aureus) and Methicillin Resistant Staphylococcus aureus (MRSA) under its collaboration with Northern Michigan University (NMU).
Micro Imaging Technology Enters Phase 1 of Its Collaboration With Northern Michigan University
Marketwire - Tue Mar 18, 7:03AM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced today that it has delivered an MIT 1000 System as part of its collaboration with Northern Michigan University (NMU) to identify and differentiate Staphylococcus aureus (S. aureus) and Methicillin Resistant Staphylococcus aureus (MRSA). As the Company previously announced, the goal of the collaboration is to rapidly and cost-effectively identify these two particular healthcare threats using the MIT 1000 System, a bacterial cell based identification system that can identify pathogenic bacteria in three minutes (average) at significant cost savings per test.
Micro Imaging Technology to Exhibit the MIT 1000 at the 2013 Food Safety Summit
Marketwire - Wed Apr 24, 1:02PM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that it will attend this year's Food Safety Summit Conference and exhibit the MIT 1000 in Baltimore, Maryland -- April 30 through May 2, 2013. Now in its 15th year, the Food Safety Summit provides important food safety information and solutions to those responsible for assuring food safety across the food supply chain.
Suit Against Micro Imaging Technology Dismissed by Texas Court
Marketwire - Mon Mar 11, 7:01AM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that on March 7th the Travis County Texas District Court granted the Company's motion to dismiss a lawsuit filed by Alpine MIT Partners, LLC (Alpine) in May 2012.
Investors Eye Catching Stocks: (OTCQB:MMTC), (NASDAQ:XRSC)
ACCESSWIRE-TNW - Tue Feb 12, 11:55PM CST
New York (February 13th, 2013) - Micro Imaging Technology, Inc. (OTCQB:MMTC) has developed and patented the MIT 1000, a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of dollars in health care costs.
Micro Imaging Technology Announces Paradigm Shift in Approach to Providing Software-Based Identification of Microbes
Marketwire - Tue Feb 12, 7:01AM CST
Micro Imaging Technology, Inc. (OTCQB: MMTC) MIT has developed and patented the MIT 1000, a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of dollars in health care costs. This technology, which the Company markets under the name Micro Identification Technologies(R), will identify bacteria in minutes at a significantly lower cost per test compared to conventional methods.
Micro Imaging Technology's Eye on the Future
Marketwire - Thu Jan 31, 7:01AM CST
Micro Imaging Technology, Inc. (OTCQB: MMTC) MIT has developed and patented the MIT 1000, a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of dollars in health care costs. This technology will identify bacteria in minutes at a significantly lower cost per test compared to conventional methods.